Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain 4Cancer Pain 4Neoplasms 3Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Signs and Symptoms 1Postoperative Complications 1Pathologic Processes 1Pain, Postoperative 1Pain Related to Cancer 1Neurologic Manifestations 1Neuralgia 1Head and Neck Neoplasms 1Chronic Pain 1Breakthrough Pain 1

Interventions

Gemcitabine 79Cisplatin 56pembrolizumab 32Paclitaxel 28Carboplatin 24Docetaxel 19Radiotherapy 17Mitomycin 16Doxorubicin 15atezolizumab 14BCG Vaccine 14Nivolumab 13Cystectomy 13Filgrastim 11vinflunine 10Methotrexate 10Vinblastine 9Fluorouracil 95-aminolevulinic acid hexyl ester 9Sunitinib 7Early Intervention, Educational 7durvalumab 6avelumab 6Taxes 6Methods 6Cystoscopy 6Albumin-Bound Paclitaxel 6enfortumab vedotin 5Trastuzumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × Methadone × Clear all
NCT04475029 2023-09-13

METAMORF

University of Aarhus

Phase NA Completed
114 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neurologic Manifestations, Pain, Pain, Postoperative, Pathologic Processes, Postoperative Complications, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡